Aspirin treatment

ApprovedSmall molecule

VVA Office of Research and Development

Aspirin treatment is one of 48 small molecule programs targeting Aneurysm. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AneurysmActive, not recruiting

Brain InfarctionActive, not recruiting

AneurysmPreclinical

Active, not recruiting

Brain InfarctionApproved

Active, not recruiting

Competition

Competitive Landscape

71 competitors in Aneurysm

#DrugCompanyPhaseTrials

Aggrastat

MMedicure

Approved

2 2

Bystolic

VVitae Pharmaceuticals Inc., an Allergan affiliate

Approved

1 3

Bayer Aspirin

Bayer

Phase 3

5 4

Brilinta

AstraZeneca

Phase 3

1 5

Urokinase

Mmedac GmbH

Approved

1 6

Zocor

OOrganon and Co

Phase 3

2 7

Epsom Salt

FFresenius Kabi Oncology Ltd.

Phase 3

1 8

Tylenol

KKenvue Brands

Phase 3

1 9

Angiomax

BBaxter Healthcare Corporation

Phase 3

1 10

Natrecor

SScios, Inc.

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

N/ARecruiting

Aneurysm

NCT07089862

Clinical

Trials by Indication[1]

Brain Infarction1 trial

Efficacy of Clopidogrel on Incidence of Silent Brain Infarction

Active, not recruiting·VVA Office of Research and Development·Phase 4·NCT04698031·134 enrolled

Aneurysm1 trial

INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)

Recruiting·—·N/A·NCT07089862·2,500 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Aspirin treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Aspirin treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Aspirin treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — VA Office of Research and Development company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: VVA Office of Research and Development

Aspirin treatment

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Brain Infarction1 trial

Aneurysm1 trial

References

Drug Info

Quick Facts

Related News